Literature DB >> 6756934

Variance comparison as a tool in clinical pharmacology: an example with two loop diuretics.

J L Imbs, M Schmidt, A Spriet, J Schwartz.   

Abstract

Comparison of variances can be usefUl in assessing the regularity of drug effects. In order to compare the variances of the saluretic effects of piretanide and frusemide, two loop diuretics with different bioavailabilities, a double-blind cross-over study was carried out in 34 normal volunteers. The diuretics were given in randomized order, with an interval of 7 days, in single equipotent doses (frusemide 6.25 mg and piretanide 1.0 mg chosen from previous results) adjusted by body weight. The dispersion of individual values (comparison of variances from paired measures) for Na+, Cl- and Ca++ excretion, urine osmolality and excretion of the drugs, was significantly smaller for piretanide than for frusemide. It is concluded that the saluretic effect of a single dose of piretanide varies less than that of an equipotent dose of frusemide. The methodology may be useful in trials of drugs for which regularity of effect is important.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756934     DOI: 10.1007/bf00547557

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  The generalisation of student's problems when several different population variances are involved.

Authors:  B L WELCH
Journal:  Biometrika       Date:  1947       Impact factor: 2.445

Review 2.  Clinical pharmacokinetics of frusemide.

Authors:  R E Cutler; A D Blair
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

3.  Some thoughts on clinical trials, especially problems of multiplicity.

Authors:  J W Tukey
Journal:  Science       Date:  1977-11-18       Impact factor: 47.728

4.  Function of the thick ascending limb of Henle's loop.

Authors:  M B Burg; N Green
Journal:  Am J Physiol       Date:  1973-03

5.  Kinetic and dynamic comparison of piretanide and furosemide.

Authors:  J R Lawrence; A F Ansari; H L Elliott; D J Sumner; G F Brunton; B Whiting; R Whitesmith
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

6.  Zomepirac: an overview--concluding remarks of the symposium chairman.

Authors:  W T Beaver
Journal:  J Clin Pharmacol       Date:  1980 May-Jun       Impact factor: 3.126

7.  Pharmacokinetics/pharmacodynamics of furosemide in man: a review.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

8.  Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.

Authors:  C J Roberts; M Homeida; F Roberts; W Bogie
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

  8 in total
  1 in total

Review 1.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.